Insider · CIK 0001291959

Davis Robert E

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001291959

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-01-08	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	SVP, Chief Scientific Officer	AAward	+75.6K sh	—	—	75,554
2019-01-08	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP, Chief Scientific Officer	AAward	+55K sh	—	—	54,988
2019-01-04	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−6,862 sh	$11.33	−$77.7K	46,691
2019-01-04	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−2,702 sh	$11.80	−$31.9K	43,989
2019-01-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−16.2K sh	—	—	32,320
2019-01-03	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+2,649 sh	—	—	37,393
2019-01-03	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+16.2K sh	—	—	53,553
2019-01-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−2,649 sh	—	—	2,649
2019-01-02	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−4,834 sh	$11.11	−$53.7K	34,744
2018-12-31	Intra-Cellular Therapies, Inc.A Award	SVP, Chief Scientific Officer	AAward	+9,322 sh	—	—	39,578
2018-12-06	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−899 sh	$13.53	−$12.2K	30,256
2018-12-04	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+1,758 sh	—	—	31,155
2018-12-04	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−1,758 sh	—	—	0
2018-01-04	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−1,115 sh	$15.60	−$17.4K	29,397
2018-01-03	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+2,648 sh	—	—	30,512
2018-01-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−2,648 sh	—	—	5,298
2018-01-03	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	SVP, Chief Scientific Officer	AAward	+65.2K sh	—	—	65,164
2018-01-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP, Chief Scientific Officer	AAward	+48.5K sh	—	—	48,480
2017-12-05	Intra-Cellular Therapies, Inc.S Sale	SVP, Chief Scientific Officer	SSale	−650 sh	$15.00	−$9,750	27,864
2017-12-04	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−1,757 sh	—	—	1,758
2017-12-04	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+1,757 sh	—	—	28,514
2017-01-03	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP, Chief Scientific Officer	AAward	+7,946 sh	—	—	7,946
2017-01-03	Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award	SVP, Chief Scientific Officer	AAward	+31.9K sh	—	—	31,858
2016-12-04	Intra-Cellular Therapies, Inc.M Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	+1,757 sh	—	—	26,757
2016-12-04	Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Scientific Officer	MExercise/Conversion	−1,757 sh	—	—	3,515
2015-12-04	Intra-Cellular Therapies, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Scientific Officer	AAward	+22.2K sh	—	—	22,230
2015-12-04	Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award	SVP, Chief Scientific Officer	AAward	+5,272 sh	—	—	5,272

Recent filings

Accepted (ET)
Jan 84
Davis Robert E0001209191-19-002955
SEC(opens sec.gov)
Jan 34
Davis Robert E0001209191-19-001584
SEC(opens sec.gov)
Dec 74
Davis Robert E0001209191-18-061525
SEC(opens sec.gov)
Jan 54
Davis Robert E0001209191-18-002591
SEC(opens sec.gov)
Dec 64
Davis Robert E0001209191-17-064255
SEC(opens sec.gov)

Companies

Address

C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET

NEW YORK, NY, 10016